Mukul Agrawal Reshuffles Rs 6,500-Crore Portfolio in Q3 with Strategic Additions and Exits

Ace investor Mukul Mahavir Agrawal executed a comprehensive portfolio reshuffling during the December quarter, making strategic adjustments to his Rs 6,500-crore equity holdings. The changes encompassed fresh additions, stake increases, position trims, and complete exits, reflecting tactical moves amid market volatility and stock-specific corrections. New Portfolio Additions Agrawal made three notable fresh entries during the quarter, targeting stocks that experienced significant corrections: Company Stake Acquired Shares (Crore) Stock Performance Hindustan Construction 1.68% 4.40 Down 30%+ over past year Alcargo Logistics 2.9% - Down 80% over last year Sudeep Pharma 1.3% - Down 30% in last year Alcargo Logistics operates as a global integrated logistics service provider, specialising in Less-than-Container Load (LCL) consolidation, ocean/air freight forwarding, and contract logistics. Sudeep Pharma serves as a major manufacturer of mineral-based pharmaceutical excipients, food-grade minerals, and specialty ingredients for pharmaceuticals, food, and nutrition industries. Stake Increases in Existing Holdings The investor selectively increased positions in three portfolio companies: Vasa Denticity saw the most significant increase, with Agrawal raising his stake by 0.4% to reach a total holding of 2.4%. The company operates as a leading Indian B2B e-commerce platform and distributor of dental products, supplying over 10,000 products including consumables, equipment, and instruments to dentists, hospitals, and clinics. Vikran Engineering received a 0.2% stake increase. The company made its stock market debut in September and trades 10% below its issue price of Rs 97. N R Agrawal witnessed a marginal 0.1% stake increase. The Mumbai-based manufacturer specialises in paper and packaging boards, including duplex boards, writing paper, and printing paper. Strategic Position Reductions Agrawal trimmed stakes across multiple high-performing holdings: Company Stake Reduction Current Holding Stock Performance Autoriders 0.7% - Up 1,100%+ in last year Zota Healthcare 0.8% 7.5% Up 40% in last year ASM Technologies 0.4% - Up 115% in last year InfoBeans Technologies 0.2% 3.9% Up 97% in last year These reductions primarily targeted stocks that delivered exceptional returns, suggesting profit-booking strategies. ASM Technologies provides engineering services and product R&D in semiconductors, industrial electronics, and digital solutions, while InfoBeans Technologies specialises in AI-led software engineering and digital transformation. Complete Portfolio Exit Stanley Lifestyles appears to have been completely exited from the portfolio, either through full sale or by reducing the stake below disclosure thresholds. The stock declined nearly 50% over the last year. Market Context and Strategy The portfolio adjustments occurred against the backdrop of sharp stock-specific corrections and a broader selloff in smallcap stocks. Agrawal's strategy demonstrates opportunistic investing in corrected names while maintaining discipline through profit-booking in outperforming positions. The Rs 6,500-crore portfolio reflects active management approach, balancing fresh opportunities with risk management across diverse sectors including logistics, pharmaceuticals, technology, and manufacturing. Prominent investor Mukul Mahavir Agrawal executed strategic portfolio changes during the December 2024 quarter, adding two new stocks to his ₹6,500-crore equity portfolio while reducing exposure to existing holdings. The market veteran, who founded Param Capital Group and brings over two decades of capital markets experience, made these moves as shareholding disclosures continue to be released. Portfolio Changes in Q3 Agrawal's recent portfolio adjustments reflect a measured approach to market opportunities and risk management: Action Stock Details New Addition Hindustan Construction Company 1.68% stake (4.40 crore shares) New Addition Sudeep Pharma 1.33% stake (15 lakh shares) Stake Reduction Monolithisch Reduced by 0.20% to 2.76% Exit Stanley Lifestyles Complete sale or below 1% threshold New Investment: Hindustan Construction Company Agrawal's entry into Hindustan Construction Company comes after the stock experienced significant correction, declining over 30% in the past year. However, the infrastructure company has demonstrated strong long-term performance with returns exceeding 170% over five years. The company operates across multiple segments including transportation, power, and water infrastructure, having executed several large-scale projects across India. Fresh Stake: Sudeep Pharma The investor also acquired a position in Sudeep Pharma, which made its stock market debut in November 2024. Currently trading approximately 1.50% above its issue price of ₹593, the company specializes in pharmaceutical ingredients, supplying mineral-based excipients and actives to clients in pharmaceutical, food, and nutrition industries. Portfolio's Multibagger Performers Despite challenging conditions for smallcap stocks throughout 2024, Agrawal's portfolio showcased five notable multibagger performers: Stock Performance Stake Details ASM Technologies 141% returns in 2024 10.70% stake, valued at ₹496 crores Zelio E-Mobility ~180% since listing 2.00% stake Monolithisch India Doubled since June listing Previously 3.00%, now 2.76% Osel Devices Doubled over past year 7.60% stake (acquired Sept 2024) Zota Health Care Doubled during year ~8.00% stake (held since Sept 2023) ASM Technologies represents Agrawal's largest individual holding by value at approximately ₹496 crores. He initially entered this position in September 2023 and increased his stake by about 4% in the September 2024 quarter. Zelio E-Mobility, which debuted in October 2024 with 1.5x subscription, manufactures and assembles electric two-wheelers and three-wheelers. Osel Devices operates in LED display systems and hearing aids manufacturing, while Zota Health Care maintains presence across generic medicines, ayurvedic products, and nutraceuticals. Market Context These portfolio adjustments occurred against a backdrop of challenging smallcap market conditions, with the smallcap index declining nearly 6% in 2024. The performance of Agrawal's multibagger holdings stands in contrast to broader market pressures, highlighting selective stock-picking success during a difficult period for smaller companies. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.